GHK-Cu
Copper peptide with wound healing, anti-aging, and anti-inflammatory properties.
Grade
Finnrick lab signal
Lowest
Trust
Current offers across tracked vendors
Lowest price first, with Finnrick grades in the same row so cost never gets divorced from lab context.
What the Finnrick results actually show
We highlight current purity and quantity results without implying every vendor or every batch has been tested equally.
Purity distribution
No Finnrick test results are attached to this peptide yet.
No Finnrick lab results are attached to this peptide yet. We leave that state explicit rather than inferring confidence that hasn't been earned.
Historical tracking comes next
The current schema gives us a trustworthy live market snapshot. It does not yet store price snapshots over time, so the chart module stays honest about that gap.
Historical pricing
Tracking starts with snapshots
The current schema stores live prices but not historical snapshots yet, so this page shows current market comparison rather than pretending time-series data exists. Once snapshots are recorded, this module can render 30-, 90-, and 180-day trends honestly.
Editorial context beyond the price table
The goal is to keep market data inside a broader research and safety frame, not let the price table become the whole story.
GHK-Cu explainer
GHK-Cu is a naturally occurring copper-binding tripeptide researched for collagen synthesis and wound healing. Topical forms appear in many cosmetic products; injectable use is not FDA-approved.
Read the full research guide →GHK-Cu Peptide Modulates Over 4,000 Human Genes Linked to Tissue Repair
Comprehensive gene expression analysis revealed that GHK-Cu upregulates pathways involved in collagen synthesis, anti-inflammatory signalling, and stem cell homing. The copper peptide complex was shown to activate 58 anti-cancer and tissue-repair genes.
Copper Peptide Concentration Found Critical for Collagen Synthesis Outcomes
New in-vitro research suggests that the concentration window for optimal GHK-Cu activity is narrower than previously thought, with both sub- and supra-therapeutic concentrations producing suboptimal collagen mRNA expression in dermal fibroblast cultures.
Research information only
Peptide Daily is an informational resource only. Peptide research chemicals are not approved for human use by the FDA unless otherwise noted. Nothing on this site constitutes medical advice. Consult a qualified healthcare provider before using any peptide or research chemical.